3/24/2022Eli Lilly/Innovent Announce Lung Cancer Drug Rejection by FDA Citing...

3/24/2022What Could Happen Next for U.S.-listed Chinese Stocks? (PharmaDJ)

3/24/2022Bracing for Volume-Based Procurement in China (Simon Kucher)

3/22/2022PharmaDJ's China Deals Tracker: February 2022

3/22/2022Transcenta Announces Global Clinical Collaboration with BMS to Evaluat...

3/21/2022China's Triastek and Siemens Strive to Accelerate Digital Transformati...

3/21/2022As AZ Sounds the Slowdown Alarm in China, Jefferies Beats the Drum for...

3/18/2022Lynk and Simcere Enter Strategic Commercialization Partnership in Chin...

3/18/2022Sinohealth: Chinese Public Hospital Drug Market Up 10.1% in 2021

3/18/2022Recent Executive Moves

3/16/2022Adagene, Merck Gets FDA Blessing P1b/2 Trial of ADG126/Keytruda Combo

3/16/2022PharmCube: An Analysis of NDAs in China

3/14/2022China Healthcare Investment Now Up To 30% Of Global Total (PharmaDJ)

3/11/2022Pharma CMO Stevanato Group Expands Capacity in China with New Facility

3/11/2022CDE Solicits Comments on Two Draft TCM Registration Guidelines

3/11/2022Recent Executive Moves

3/10/2022AmCham Survey, U.S. Firms Less Optimistic About Making New Investments...

3/10/2022SEC Sets Clock for Delisting Chinese Companies Over US Audit Demand (U...

3/9/2022Snapshot of MNC Pharma's China Performance in 2021 (Updated)

3/9/2022Lonza Expands API Development and Manufacturing Laboratories in Nansha

3/9/2022Hanmi to Launch High Blood Pressure Drug Amosartan in China

3/9/2022China Meheco Inks Deal to Market Pfizer's Covid Pill Paxlovid in China

3/7/2022Altamira and Nuance Enter Licensing and Distribution Deal for Bentrio ...

3/7/2022Hutchmed Gets $15M from AstraZeneca as Part of Orpathys Drug Program i...

3/7/2022NHSA Releases Its 2021 Healthcare Security Sector Development Statisti...

3/7/2022NHC Establishes the Pharmacy Management and Drug Therapy Committee

3/7/2022Central Government Report Emphasizes on Nine Healthcare Reform Measure...

3/4/2022Recent Executive Moves

3/3/2022WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at ...

3/3/2022Lesson from China's National Negotiation of Drug Prices in 2021 (NLR)

Page:47/333 Total number of articles:9989: [First][<<] [45] [46] [47] [48] [49] [>>] [End]